![PIERRE FABRE GROUP Accelerating online growth with a global e-Retail upskilling programme - Artefact PIERRE FABRE GROUP Accelerating online growth with a global e-Retail upskilling programme - Artefact](https://www.artefact.com//wp-content/uploads/2021/06/pierre-fabre-laboratory.jpeg)
PIERRE FABRE GROUP Accelerating online growth with a global e-Retail upskilling programme - Artefact
![Pierre Fabre is taking a minority stake, via its dedicated investment subsidiary Pierre Fabre Invest, in Gennisium Pharma, an innovative company specializing in medicines for premature newborns and niche markets - Adnkronos.com Pierre Fabre is taking a minority stake, via its dedicated investment subsidiary Pierre Fabre Invest, in Gennisium Pharma, an innovative company specializing in medicines for premature newborns and niche markets - Adnkronos.com](https://mma.prnewswire.com/media/1916090/Pierre_Fabre_Gennisium__Logo.jpg)
Pierre Fabre is taking a minority stake, via its dedicated investment subsidiary Pierre Fabre Invest, in Gennisium Pharma, an innovative company specializing in medicines for premature newborns and niche markets - Adnkronos.com
![Pierre Fabre e la Fondazione EspeRare avviano lo studio clinico EDELIFE su un trattamento prenatale per una rara malattia genetica, la XLHED Pierre Fabre e la Fondazione EspeRare avviano lo studio clinico EDELIFE su un trattamento prenatale per una rara malattia genetica, la XLHED](https://mma.prnewswire.com/media/1688212/Pierre_Fabre_and_EspeRare_Logo.jpg?p=facebook)
Pierre Fabre e la Fondazione EspeRare avviano lo studio clinico EDELIFE su un trattamento prenatale per una rara malattia genetica, la XLHED
![Ebvallo® (tabelecleucel) di Atara Biotherapeutics ha ricevuto l'approvazione da parte della Commissione europea ad essere la prima terapia per pazienti adulti e pediatrici con EBV+ PTLD Ebvallo® (tabelecleucel) di Atara Biotherapeutics ha ricevuto l'approvazione da parte della Commissione europea ad essere la prima terapia per pazienti adulti e pediatrici con EBV+ PTLD](https://mma.prnewswire.com/media/1970795/Pierre_Fabre_Atara_Logo.jpg?p=facebook)